0001725255 false 0001725255 2021-11-19 2021-11-19 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 19, 2021

 

 

AdaptHealth Corp.

(Exact name of registrant as specified in its charter)

 

Delaware   001-38399   82-3677704
(State or other jurisdiction of
incorporation)
  (Commission File Number)   (IRS Employer Identification No.)

 

220 West Germantown Pike, Suite 250

Plymouth Meeting, PA

  19462
(Address of principal executive offices)   (Zip Code)
     
(610) 630-6357

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.0001 per share AHCO The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

 

 

 

 

 

Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.

 

(b) On November 19, 2021, Frank Mullen, the Chief Accounting Officer of AdaptHealth Corp., a Delaware corporation (the “Company”), notified the Company that he will be leaving the Company effective May 16, 2022. Mr. Mullen has indicated to the Company that his departure is not the result of any dispute or disagreement regarding the Company’s financial reporting or disclosures or the Company’s accounting policies, principles, practices, procedures, estimates or judgments. Mr. Mullen informed the Company that he was resigning for personal reasons and will assist the Company in connection with the transition of his duties to his successor.

 

- 2 -

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

Dated: November 19, 2021

 

  AdaptHealth Corp.
   
  By: /s/ Jason Clemens
    Name: Jason Clemens
    Title: Chief Financial Officer

 

- 3 -

 

AdaptHealth (NASDAQ:AHCO)
Historical Stock Chart
From Dec 2021 to Jan 2022 Click Here for more AdaptHealth Charts.
AdaptHealth (NASDAQ:AHCO)
Historical Stock Chart
From Jan 2021 to Jan 2022 Click Here for more AdaptHealth Charts.